Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Switzerland

European Research Council grant · Running

MicroSwiss MicroSwiss: Affordable Add-On for Polarization, Lifetime, & Super-Resolved Imaging and Tracking

Coordinator
Ecole Polytechnique Federale De Lausanne, Switzerland
Runs
1 March 2026 to 31 August 2027
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101248059

What the project is doing

In the project's own words, from its summary on CORDIS.

MicroSwiss aims to develop and validate a plug-and-play microscopy add-on that enhances fluorescence microscopy by combining super-resolution imaging, fluorescence lifetime multiplexing, molecular orientation analysis, and high-speed single-particle tracking into a compact system. This innovative approach overcomes key limitations of current imaging techniques, including hardware complexity, high costs, slow acquisition speeds, and restricted molecular orientation tracking.

Addressing these challenges makes high-resolution imaging more accessible to the broader scientific community. The project will first focus on prototype development, integrating a polarization-sensitive prism system, a SPAD-based fluorescence lifetime extraction module, and novel algorithms into a functional imaging system with custom software. This system will enable molecular tracking and fluorescence lifetime analysis, providing researchers with new capabilities to study dynamic biological processes at nanometre resolution.

Next, the project will demonstrate the effectiveness and robustness of the add-on across different biological systems and experimental conditions. Benchmarking experiments will evaluate aerolysin pore formation dynamics, molecular diffusion, and orientation-sensitive imaging in varied membrane environments. Planned validation experiments will establish MicroSwiss as a versatile and reliable tool for studying protein assembly and molecular interactions.

Beyond technical validation, the project will assess commercialization potential, including market positioning, IP strategy, and business development. Collaboration with EPFL’s Enable program and industry partners will support the transition from prototype to minimum viable product. By the project’s end, MicroSwiss will have reached TRL 5 with a clear roadmap for commercialization through licensing, partnerships, or a dedicated start-up, ensuring its impact in academic research, drug discovery, and nanotechnology applications

Topics

Who is involved

OrganisationCityCountryRole
Ecole Polytechnique Federale De LausanneLausanneSwitzerlandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI